English
Home > Products > Thymosin α1

China Thymosin α1 Factory

We have now a specialist, efficiency staff to provide good quality company for our consumer. We normally follow the tenet of customer-oriented, details-focused for Thymosin α1,CAS NO 62304-98-7,62304-98-7,69440-99-9,CAS NO 69440-99-9, should you may have any query or wish to place an initial purchase be sure to never hesitate to contact us.
Thymosin α1, Faced with the vitality of the global wave of economic integration, we are confident with our high-quality products and sincerely service to all our customers and wish we can cooperate with you to create a brilliant future.

Related Products

Hot Products

  • ethyl 4-(3-oxoMorpholino) phenylcarbaMate

    ethyl 4-(3-oxoMorpholino) phenylcarbaMate

    Product Name:ethyl 4-(3-oxoMorpholino) phenylcarbaMate
    Molecular Formula:C13H16N2O4
    Molecular Weight:264.28
    CAS Registry Number:1327778-39-1
  • 5-Fluoro-4-Iodo-2-Pyridinamine

    5-Fluoro-4-Iodo-2-Pyridinamine

    Product Name:5-Fluoro-4-Iodo-2-Pyridinamine
    Molecular Formula:C5H4FIN2
    Molecular Weight:238.00
    CAS Registry Number:1649470-53-0
  • Lycopene

    Lycopene

    Product Name:Lycopene
    Molecular Formula:C40H56
    Molecular Weight:536.87
    CAS Registry Number:502-65-8
  • 3-(3,5-bis(trifluoroMethyl)phenyl)-1H-1,2,4-triazole

    3-(3,5-bis(trifluoroMethyl)phenyl)-1H-1,2,4-triazole

    Product Name:3-(3,5-bis(trifluoroMethyl)phenyl)-1H-1,2,4-triazole
    Molecular Formula:C10H5F6N3
    Molecular Weight:281.16
    CAS Registry Number:1333154-10-1
  • Trimethoprim

    Trimethoprim

    Product Name:Trimethoprim
    Molecular Formula:C14H18N4O3
    Molecular Weight;290.32
    CAS Registry Number;738-70-5
  • DM4

    DM4

    Product Name:DM4
    Molecular Formula:C38H54ClN3O10S
    Molecular Weight:780.37
    CAS Registry Number:796073-69-3
  • Related Blog
  • Reviews

  • What are the raw materials required for pharmaceutical industry?

    Pharmaceutical industry has a lot of constraints and specialties which make it stand on a completely differents scale than any other industries. Being closely related to the medical field and also complementary to it, the pharmaceutical industry needs utmost care and precision in each and every aspect of the field ranging from collecting the raw materials to getting the final product ready for supply in the market.

  • Pharmaceutical Intermediates Manufacturers - Something You Need to Know About Pharma Intermediates Industry

    Pharmaceutical intermediates are actually chemical raw materials or chemical products that need to be used in the synthesis of drugs. Such chemical products can be produced in ordinary chemical plants without obtaining a pharmaceutical production license. As long as the technical indicators meet certain level requirements, they can be used to participate in the synthesis and production of drugs.

  • Baloxavir marboxil

    Baloxavir marboxil is used to treat flu symptoms caused by influenza virus in people who have had symptoms for no more than 48 hours. Baloxavir marboxil will not treat the common cold. Baloxavir marboxil is for adults and children who are at least 12 years old and weigh at least 88 pounds (40 kilograms).

  • What is the difference between API and FDF in pharma？

    In the pharmaceutical industry, you might hear the terms “FDF” and “API” frequently used in reference to products. We surely understand this type of jargon, but we certainly can see how the general public would feel overwhelmed looking at those kinds of terminology abbreviations. This article is for explaining the difference between API and FDF. For reference, they mean, respectively, “finished dosage form” and “active pharmaceutical ingredient.”

  • FDA approves lorlatinib for second- or third-line treatment of ALK-positive metastatic NSCLC

    On November 2, 2018, the Food and Drug Administration granted accelerated approval to lorlatinib (LORBRENA, Pfizer, Inc.) for patients with anaplastic lymphoma kinase (ALK)-positive metastatic non-small cell lung cancer (NSCLC) whose disease has progressed on crizotinib and at least one other ALK inhibitor for metastatic disease or whose disease has progressed on alectinib or ceritinib as the first ALK inhibitor therapy for metastatic disease.

  • What Is Ursodeoxycholic Acid Used For?

    Ursodeoxycholic acid is a cholelithiant commonly used in the gastroenterology department, and also a cholelithiasis dissolving agent, so it can be used in the treatment of gallstones under normal circumstances, on the premise...

Related Search

Thymosin α1 API

Send Inquiry

Hit enter to search or ESC to close
X
We use cookies to offer you a better browsing experience, analyze site traffic and personalize content. By using this site, you agree to our use of cookies. Privacy Policy
Reject Accept